NEW DELHI, May 7: For millions of patients, a medicine strip is an object of faith. The label, the packaging, the pharmacy counter — all of it creates the belief that what is being consumed is genuine, tested, and safe.
But a major Delhi Police operation has exposed how dangerous that blind trust can be.
Police have busted an alleged four-member syndicate accused of manufacturing and distributing counterfeit life-saving medicines used for serious illnesses, including cancer and liver disease. Investigators say the fake drugs were being pushed into markets across parts of India, placing vulnerable patients at grave risk.
Fake Drugs for Patients Who Could Least Afford the Risk
According to police, the gang was not dealing in ordinary products. It allegedly targeted some of the most critical categories of medicines — the kind used by patients fighting life-threatening diseases.
Officials said the counterfeit drugs were designed to look like genuine products, with packaging so carefully copied that pharmacists and patients could easily be deceived.
This is what makes the case especially alarming: patients may have believed they were receiving treatment, while in reality they could have been consuming ineffective or dangerous substitutes.
Alleged Mastermind Turned to Counterfeit Pharma After Pandemic Losses
Police have identified the alleged mastermind as Manoj Kumar Mishra , originally from Manipur.
Investigators say Mishra was earlier involved in the business of surgical gloves and masks during the pandemic. After that business reportedly collapsed in 2022, he allegedly shifted to the illegal and highly profitable counterfeit medicine trade.
The operation was allegedly run under the cover of a company named Unitel Pharma , through which fake medicines were distributed in parts of Northeast and East India.
A Professional-Looking Operation
What stunned investigators was the level of sophistication.
The gang allegedly used advanced machinery to manufacture packaging that closely resembled genuine medicine brands. Police believe this helped the syndicate pass off counterfeit drugs as authentic products in the market.
In other words, this was not a crude street-level operation. It was allegedly a polished racket built to exploit trust — trust in brands, in pharmacies, and in the healthcare system.
Healthcare Supply Chain Under Scanner
The investigation has also raised serious questions about breaches in the medical supply chain.
Police have named Raju Mishra as a key associate in the alleged manufacturing network.
Two others — Vikram Singh and Watan Saini — are accused of diverting genuine medicines from the Central Government Health Scheme and supplying them to the syndicate.
If proven, this would point to a disturbing loophole: medicines meant for legitimate government healthcare channels may have been siphoned off and misused to support a fake drug network.
Seizure Worth Around ₹10 Crore (KD 346,000)
During coordinated raids, police seized material worth approximately ₹10 crore , including:
More than 90,000 capsules and assorted counterfeit pills – Heavy-duty manufacturing and packaging machines
Fake labels and packaging material
Documents allegedly linked to the distribution network
Records suggesting illegal profits worth crores
Officials are now trying to determine how widely the counterfeit medicines were circulated and how many patients may have been affected.
Investigation Expands Across States
Police are tracing the full distribution chain to identify the states where the fake drugs were sold. Investigators are also examining whether more people inside or outside the healthcare supply system helped the accused.
Officials said further revelations may emerge as questioning of the four accused continues.
A Warning for Patients and Families
This case is a harsh reminder that medicine should never be trusted blindly — especially when dealing with expensive or life-saving drugs.
Patients and caregivers should:
– Buy medicines only from licensed and trusted pharmacies
– Check batch numbers, expiry dates and packaging quality
– Be cautious of unusually large discounts on costly medicines
– Verify high-value drugs with the manufacturer when in doubt
– Avoid buying critical medicines through unknown online sellers or informal networks
– Report suspicious medicines to authorities immediately
The Delhi bust shows that counterfeit medicine is not just a financial crime. It is a direct attack on patients who are already fighting for their lives.